Higher Energy Expenditure in Humans Predicts Natural Mortality

Obesity and Diabetes Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85016, USA.
The Journal of Clinical Endocrinology and Metabolism (Impact Factor: 6.21). 03/2011; 96(6):E972-6. DOI: 10.1210/jc.2010-2944
Source: PubMed

ABSTRACT Higher metabolic rates increase free radical formation, which may accelerate aging and lead to early mortality.
Our objective was to determine whether higher metabolic rates measured by two different methods predict early natural mortality in humans.
Nondiabetic healthy Pima Indian volunteers (n = 652) were admitted to an inpatient unit for approximately 7 d as part of a longitudinal study of obesity and diabetes risk factors. Vital status of study participants was determined through December 31, 2006. Twenty-four-hour energy expenditure (24EE) was measured in 508 individuals, resting metabolic rate (RMR) was measured in 384 individuals, and 240 underwent both measurements on separate days. Data for 24EE were collected in a respiratory chamber between 1985 and 2006 with a mean (SD) follow-up time of 11.1 (6.5) yr and for RMR using an open-circuit respiratory hood system between 1982 and 2006 with a mean follow-up time of 15.4 (6.3) yr. Cox regression models were used to test the effect of EE on natural mortality, controlled for age, sex, and body weight.
In both groups, 27 natural deaths occurred during the study period. For each 100-kcal/24 h increase in EE, the risk of natural mortality increased by 1.29 (95% confidence interval = 1.00-1.66; P < 0.05) in the 24EE group and by 1.25 (95% confidence interval = 1.01-1.55; P < 0.05) in the RMR group, after adjustment for age, sex, and body weight in proportional hazard analyses.
Higher metabolic rates as reflected by 24EE or RMR predict early natural mortality, indicating that higher energy turnover may accelerate aging in humans.

Download full-text


Available from: Reiner Jumpertz-von Schwartzenberg, Jan 29, 2014
176 Reads
  • Source
    • "This indicates that in aging, resting metabolism may decrease through other mechanisms such as reduction in the mass and metabolic rate of individual organs and tissues. An increase in resting metabolic rate, as is observed in pathological conditions, accelerates aging and leads to early mortality (Ruggiero et al., 2008; Jumpertz et al., 2011). Consistently, a reduction in metabolic rate, such as in caloric restriction, improves several biological parameters and has a favorable impact on longevity in both animal models and humans (Mattson and Wan, 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The brown fat specific UnCoupling Protein 1 (UCP1) is involved in thermogenesis, a process by which energy is dissipated as heat in response to cold stress and excess of caloric intake. Thermogenesis has potential implications for body mass control and cellular fat metabolism. In fact, in humans, the variability of the UCP1 gene is associated with obesity, fat gain and metabolism. Since regulation of metabolism is one of the key-pathways in lifespan extension, we tested the possible effects of UCP1 variability on survival. Two polymorphisms (A-3826G and C-3740A), falling in the upstream promoter region of UCP1, were analyzed in a sample of 910 subjects from southern Italy (475 women and 435 men; age range 40-109). By analyzing haplotype specific survival functions we found that the A-C haplotype favors survival in the elderly. Consistently, transfection experiments showed that the luciferase activity of the construct containing the A-C haplotype was significantly higher than that containing the G-A haplotype. Interestingly, the different UCP1 haplotypes responded differently to hormonal stimuli. The results we present suggest a correlation between the activity of UCP1 and human survival, indicating once again the intricacy of mechanisms involved in energy production, storage and consumption as the key to understanding human aging and longevity.
    Experimental gerontology 07/2011; 46(11):897-904. DOI:10.1016/j.exger.2011.07.011 · 3.49 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mild abnormalities of thyroid function have been associated with both beneficial and detrimental effects on mortality. Our objective was to determine the association between continuous TSH as well as categories of thyroid function with total and cause-specific mortality in a cohort of older men. Data were analyzed from the Osteoporotic Fractures in Men (MrOS) study, a cohort of community-dwelling U.S. men aged 65 yr and older. A total of 1587 participants randomly selected for thyroid function testing were included in this analysis. TSH and free T4 were measured at baseline, and four categories of thyroid function were defined. (subclinical hyperthyroid; euthyroid; subclinical hypothyroid TSH<10 mIU/liter; and subclinical hypothyroid, TSH≥10 mIU/liter.) Total mortality, cardiovascular (CV) and cancer deaths were confirmed by review of death certificates. There were 432 deaths over a mean follow-up of 8.3 yr. In fully adjusted models, there was no association between baseline TSH and any death [relative hazard (RH)=1.01 per mIU/liter, 95% confidence interval (CI)=0.95-1.06], CV death (RH=1.05 per mIU/liter, 95% CI 0.96-1.15), or cancer death (RH=0.96 per mIU/liter, 95% CI=0.85-1.07). There was also no statistically significant association between thyroid function category and total or cause-specific mortality, but few men (n=8) had subclinical hypothyroidism with TSH levels of 10 mIU/liter or higher. A single measurement of thyroid function did not predict total or cause-specific mortality in this cohort. These data support neither a beneficial nor a detrimental effect of subclinical thyroid dysfunction in older men. Subclinical thyroid dysfunction is not associated with an increased risk of all-cause or CV mortality in older men.
    The Journal of Clinical Endocrinology and Metabolism 03/2012; 97(3):862-70. DOI:10.1210/jc.2011-2684 · 6.21 Impact Factor
  • Journal of the American Geriatrics Society 09/2012; 60(9):1768-9. DOI:10.1111/j.1532-5415.2012.04102.x · 4.57 Impact Factor
Show more